Clinical Trials in Ohio

Showing 3141-3160 of 20,938 trials

Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

NCT02990793

The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder

PostTraumatic Stress DisorderTraumatic Brain InjuryPostconcussive Symptoms

Wave Neuroscience158 participantsStarted Apr 2022

Costa Mesa, California, United States • Long Beach, California, United States • San Diego, California, United States +5 more locations

Active Not RecruitingPhase 383 miles

A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

NCT06104124

Primary Objective: To evaluate the effect of dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity. Secondary Objectives: 1. To evaluate the effect of dazodalibep on patient reported outcomes (PROs) in participants with SS. 2. To evaluate the safety and tolerability of dazodalibep in participants with SS

Sjogren's Syndrome

Amgen651 participantsStarted Jan 2024

Avondale, Arizona, United States • Chandler, Arizona, United States • Flagstaff, Arizona, United States +213 more locations

Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Find Trials by Condition in Ohio

iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

Study of Serine Supplementation to Protect Vision in MacTel

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

Prostate Active Surveillance Study

The Safety and Efficacy of SYD-101 in Children With Myopia

Perf-Fix Study for Chronic Tympanic Membrane Repair

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients